These rodent data are partially recapitulated in individuals with lipodystrophy which exhibit chronically low levels of leptin (109, 110) and are at a greater risk to the development of OSA (111), suggesting that insufficient leptin action may lead to OSA in humans. The gene discussed is LEP; the disease is lipodystrophy.